The Center for Regenerative Medicine (CReM) is a joint effort between Boston University and Boston Medical Center that nucleates eight principal investigators addressing different aspects of developmental biology, stem cells and cell lineage specification with a major focus on induced Pluripotent Stem Cells or iPSC. With the motto of “Advancing Science to Heal the World” at the CReM we aim at better understanding the biological principles that guide cellular identity and tissue formation to develop the next generation tools for regenerative medicine.
iPS CELLS ?
Induced pluripotent stem cells are derived from the donated skin or blood cells of adults and, with the reactivation of four genes, are reprogrammed back to an embryonic stem cell-like state. Like embryonic stem cells, iPS cells can be differentiated toward any cell type in the body, but they do not require the use of embryos. Since this discovery our knowledge about iPS cells has exponentially expanded.Read more
iPS Cell Colonies
Follow here what has been happening at the CReM, our recent papers, awards and events!